{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:38:58Z","timestamp":1791185938227,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Suven Life Sciences Ltd."}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.ejmech.2015.08.051","type":"journal-article","created":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T05:13:08Z","timestamp":1441084388000},"page":"289-301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["Synthesis and SAR of Imidazo[1,5-a]pyridine derivatives as 5-HT4 receptor partial agonists for the treatment of cognitive disorders associated with Alzheimer's disease"],"prefix":"10.1016","volume":"103","author":[{"given":"Ramakrishna","family":"Nirogi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Rasheed","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil K.","family":"Shinde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narsimha","family":"Bogaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shankar Reddy","family":"Gagginapalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivasa Rao","family":"Ravella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laxman","family":"Kota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopinadh","family":"Bhyrapuneni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nageswara Rao","family":"Muddana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Benade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghava Chowdary","family":"Palacharla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"Jayarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramkumar","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod Kumar","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2015.08.051_bib1","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1602\/neurorx.2.4.612","article-title":"Current concepts in therapeutic strategies targeting cognitive decline and disease modification in Alzheimer's disease","volume":"4","author":"Jacobsen","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.ejmech.2015.08.051_bib2","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1476-5381.1995.tb13303.x","article-title":"5-Hydroxytryptamine (5-HT4) receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases","volume":"114","author":"Reynolds","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2015.08.051_bib3","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0022-3565(24)38802-0","article-title":"Evidence for involvement of Central 5-HT4 receptors in cholinergic function associated with cognitive processes: behavioral, electrophysiological, and neurochemical studies","volume":"296","author":"Matsumoto","year":"2001","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2015.08.051_bib4","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0028-3908(96)00169-4","article-title":"5-HT4 receptors improve social olfactory memory in the rat","volume":"36","author":"Letty","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2015.08.051_bib5","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0028-3908(97)00058-0","article-title":"BIMU1 increases associative memory in rats by activating 5-HT4 receptors","volume":"36","author":"Marchetti-Gauthier","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2015.08.051_bib6","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.expneurol.2006.07.021","article-title":"Activation of 5-HT4 receptors inhibits secretion of beta-amyloid peptides and increases neuronal survival","volume":"203","author":"Cho","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejmech.2015.08.051_bib7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.expneurol.2007.02.001","article-title":"5-HT4 receptor and Alzheimer's disease: the amyloid connection","volume":"205","author":"Lezoualc'h","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejmech.2015.08.051_bib8","doi-asserted-by":"crossref","first-page":"44881","DOI":"10.1074\/jbc.M109008200","article-title":"The human serotonin 5-HT4 receptor regulates secretion of non-amyloidogenic precursor protein","volume":"276","author":"Robert","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2015.08.051_bib9","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.bjp.0707178","article-title":"5-HT4 receptor agonists increase sAPPalpha levels in the cortex and hippocampus of male C57BL\/6j mice","volume":"150","author":"Cachard-Chastel","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2015.08.051_bib10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3389\/fnagi.2013.00096","article-title":"Early administration of RS 67333, a specific 5-HT4 receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer's disease","volume":"5","author":"Giannoni","year":"2013","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ejmech.2015.08.051_bib11","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.neuron.2007.07.041","article-title":"Serotonin 4 (5-HT4) receptor agonists are putative antidepressants with a rapid onset of action","volume":"55","author":"Lucas","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2015.08.051_bib12","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1517\/13543784.2010.482927","article-title":"New-Generation 5-HT4 receptor agonists: potential for treatment of gastrointestinal motility disorders","volume":"19","author":"Manabe","year":"2010","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ejmech.2015.08.051_bib13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2982.2007.01059.x","article-title":"5-HT4 receptor agonists: similar but not the same","volume":"20","author":"De Maeyer","year":"2008","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.ejmech.2015.08.051_bib14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4236\/nm.2011.22013","article-title":"5-HT4 receptor agonists for the treatment of Alzheimer's disease","volume":"2","author":"Ahmad","year":"2011","journal-title":"Neurosci. Med."},{"key":"10.1016\/j.ejmech.2015.08.051_bib15","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1021\/jm020099f","article-title":"5-HT4 receptor ligands: applications and new prospects","volume":"46","author":"Langlois","year":"2003","journal-title":"J.\u00a0Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2015.08.051_bib16","doi-asserted-by":"crossref","first-page":"334","DOI":"10.2174\/092986710790192730","article-title":"Serotonin 5-HT3 and 5-HT4 ligands: an update of medicinal chemistry research in the past few years","volume":"17","author":"Modica","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.08.051_bib17","doi-asserted-by":"crossref","first-page":"9240","DOI":"10.1021\/jm300953p","article-title":"Identification of multiple 5-HT4 partial agonist clinical candidates for the treatment of Alzheimer's disease","volume":"55","author":"Brodney","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.08.051_bib18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejmech.2014.05.015","article-title":"Synthesis and structure-activity relationship studies in serotonin 5-HT4 receptor ligands based on a benzo[de][2,6]naphthridine scaffold","volume":"82","author":"Castriconi","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.08.051_bib19","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.ejmech.2013.03.060","article-title":"Synthesis and pharmacological properties of a new hydrophilic and orally bioavailable 5-HT4 antagonist","volume":"64","author":"Brudeli","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.08.051_bib20","series-title":"RQ-00000009, a Selective 5-HT4 Receptor Partial Agonist Suppressed Brain Amyloid-\u03b2 Protein Levels and Improved Memory and Cognitive Performances in Rodents","first-page":"P3","author":"Fujiuchi","year":"2010"},{"key":"10.1016\/j.ejmech.2015.08.051_bib21","unstructured":"Ohshiro H., Fujiuchi A., Take Y. 5-HT4 receptor agonists for the treatment of dementia. PCT Pat. Appl. WO 2011\/099305 A1, 18 Aug. 2011."},{"key":"10.1016\/j.ejmech.2015.08.051_bib22","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.neuropharm.2007.06.016","article-title":"VRX-03011, a novel 5-HT4 agonist, enhances memory and hippocampal acetylcholine efflux","volume":"53","author":"Mohler","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2015.08.051_bib23","series-title":"Results of a Phase 2A Study of a Novel 5HT4 Agonist for the Treatment of Alzheimer's Disease","first-page":"073008","author":"Thomas","year":"2008"},{"key":"10.1016\/j.ejmech.2015.08.051_bib24","series-title":"Society for Neuroscience Annual Meeting (SfN)","first-page":"P1","article-title":"SUVN-D4010: novel 5-HT4 receptor partial agonist for the treatment of Alzheimer's disease","author":"Muddana","year":"2013"},{"key":"10.1016\/j.ejmech.2015.08.051_bib25","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1021\/jm900881j","article-title":"A\u00a0multivalent approach to the design and discovery of orally efficacious 5-HT4 receptor agonists","volume":"52","author":"McKinnell","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.08.051_bib26","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1021\/jm970857f","article-title":"Synthesis and structure\u2212activity relationships of potent and orally active 5-HT4 receptor antagonists: Indazole and benzimidazolone derivatives","volume":"41","author":"Schaus","year":"1998","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.08.051_bib27","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1021\/jm00058a004","article-title":"Substituted benzamides with conformationally restricted side chains. 5-Azabicyclo[x.y.z] derivatives as 5-HT4 receptor agonists and gastric motility stimulants","volume":"36","author":"King","year":"1993","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.08.051_bib28","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1021\/jm981098j","article-title":"2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT4 receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives","volume":"42","author":"Tapia","year":"1999","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.08.051_bib29","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2174\/156802610791111551","article-title":"Review of 5-HT4R ligands: state of art and clinical applications","volume":"10","author":"Bureau","year":"2010","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.08.051_bib30","unstructured":"Becker D.P., Flynn D.L., Moormann A.E., Villamil C.I. New meso-azacyclic amides of imidazopyridine carboxylic acids and analogues thereof. U.S. Pat. 5,430,040, Jul. 4. 1995."},{"key":"10.1016\/j.ejmech.2015.08.051_bib31","unstructured":"King F.D., Gaster L.M., Joiner G.F. Imidazopyridines and indolizines as 5-HT4 antagonists. PCT Pat. Appl. WO 1993\/008187 A1, 29 Apr. 1993."},{"key":"10.1016\/j.ejmech.2015.08.051_bib32","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1021\/jm0509501","article-title":"Pyrrolizidine esters and amides as 5-HT4 receptor agonists and antagonists","volume":"49","author":"Becker","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.08.051_bib33","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1021\/jm960853v","article-title":"Arylcarbamate derivatives of 1-piperidinethanol as potent ligands for 5-HT4 receptors","volume":"40","author":"Soulier","year":"1997","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.08.051_bib34","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/jhet.5570280712","article-title":"Heterocycles from amino acids. A novel synthetic approach for Imidazo[1,5-\u03b1]pyridines and Imidazo[1,5-\u03b1]quinolines","volume":"28","author":"Kolar","year":"1991","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2015.08.051_bib35","unstructured":"Kim S., Im W., Choi S., Choi S., Sohn J., Sung H., Kim M., Cho K., Sohn T. Novel benzamide derivatives. PCT Pat. Appl. WO 2011\/132901 A2, 27 Oct. 2011."},{"key":"10.1016\/j.ejmech.2015.08.051_bib36","unstructured":"Nirogi R., Mohammed A.R., Yarlagadda S., Ravella S., Shinde A.K., Kambhampati R., Royalley P.K., Jayarajan P., Bhairapuneni G., Patnala S.M., Ravula J., Jasti V. Heteroaryl compounds as 5-HT4 receptor ligands. PCT Pat. Appl. WO 2013\/042135 A1, 28 Mar. 2013."},{"key":"10.1016\/j.ejmech.2015.08.051_bib37","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1248\/cpb.42.877","article-title":"Synthesis and biological activities of the optical isomers of (\u00b1)-4-amino-5-chloro-2-ethoxy-N-[[4-(4-fluorobenzyl)-2-morpholinyl]methyl]benzamide (Mosapride)","volume":"42","author":"Morie","year":"1994","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2015.08.051_bib38","unstructured":"Marquess D., Choi S., Fatheree P.R., Gendron R., Goldblum A.A., Long D.D., Turner S.D., Liu J. Indazole-carboxamide derivatives as 5-HT4 receptor agonists. PCT Pat. Appl. WO 2005\/080389 A1, 1 Sep. 2005."},{"key":"10.1016\/j.ejmech.2015.08.051_bib39","doi-asserted-by":"crossref","first-page":"8663","DOI":"10.1021\/jm101177s","article-title":"Discovery of 2-(6-{[(6-Fluoroquinolin-2-yl)methyl]amino} bicyclo[3.1.0]hex-3-yl)- N-hydroxypyrimidine-5-carboxamide (CHR-3996) a class I selective orally active histone deacetylase inhibitor","volume":"53","author":"Moffat","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.08.051_bib40","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1055\/s-1996-5684","article-title":"Synthesis of (1\u03b1,5\u03b1,6\u03b1)-6-Amino-3-azabicyclo[3,1,0]hexane, a novel achiral diamine","author":"Brighty","year":"1996","journal-title":"Synlett"},{"key":"10.1016\/j.ejmech.2015.08.051_bib41","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/sj.bjp.0705950","article-title":"New insights into the human 5-HT4 receptor binding site: exploration of a hydrophobic pocket","volume":"143","author":"Rivail","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2015.08.051_bib42","doi-asserted-by":"crossref","first-page":"20812","DOI":"10.1074\/jbc.M112216200","article-title":"5-Hydroxytryptamine 4(a) receptor is coupled to the Galpha subunit of heterotrimeric G13 protein","volume":"277","author":"Ponimaskin","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2015.08.051_bib43","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.bjp.0703101","article-title":"Isolation of the serotoninergic 5- HT4(e) receptor from human heart and comparative analysis of its pharmacological profile in C6-glial and CHO cell lines","volume":"129","author":"Mialet","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2015.08.051_bib44","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1021\/jm2013248","article-title":"Oxadiazoles in medicinal chemistry","volume":"55","author":"Bostrom","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.08.051_bib45","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.brainres.2012.03.013","article-title":"Difference in the norepinephrine levels of experimental and non-experimental rats with age in the object recognition task","volume":"1453","author":"Nirogi","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.ejmech.2015.08.051_bib46","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s13318-012-0081-1","article-title":"Concurrent administration of atypical antipsychotics and donepezil: drug interaction study in rats","volume":"37","author":"Nirogi","year":"2012","journal-title":"Eur. J. Drug. Metab. Pharmacokinet."},{"key":"10.1016\/j.ejmech.2015.08.051_bib47","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2004"},{"issue":"1","key":"10.1016\/j.ejmech.2015.08.051_bib48","doi-asserted-by":"crossref","first-page":"e87014","DOI":"10.1371\/journal.pone.0087014","article-title":"Regulation of amyloid precursor protein processing by serotonin signaling","volume":"9","author":"Pimenova","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2015.08.051_bib49","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/jphp.12030","article-title":"In-vivo rat striatal 5-HT4 receptor occupancy using non-radiolabelled SB207145","volume":"65","author":"Nirogi","year":"2013","journal-title":"J.\u00a0Pharm. Pharmacol."},{"key":"10.1016\/j.ejmech.2015.08.051_bib50","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1124\/jpet.105.100172","article-title":"Pharmacological evidence for a functional serotonin-2B receptor in a human uterine smooth muscle cell line","volume":"17","author":"Kelly","year":"2006","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2015.08.051_bib51","first-page":"1075","article-title":"Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells","volume":"127","author":"Porter","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2015.08.051_bib52","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/sj.bjp.0702632","article-title":"RS-127445: a selective, high affinity, orally bioavailable 5-HT2B receptor antagonist","volume":"127","author":"Bonhaus","year":"1999","journal-title":"Br. J. Pharmacol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523415302348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523415302348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T10:03:14Z","timestamp":1748599394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523415302348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":52,"alternative-id":["S0223523415302348"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2015.08.051","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and SAR of Imidazo[1,5-a]pyridine derivatives as 5-HT4 receptor partial agonists for the treatment of cognitive disorders associated with Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2015.08.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}